Bupropion News and Research

RSS
New study shows decline in benefits from smoking cessation medications over time

New study shows decline in benefits from smoking cessation medications over time

Drugs alone may not improve chances of successful quitting among smokers, study suggests

Drugs alone may not improve chances of successful quitting among smokers, study suggests

Simple finger-prick blood test can help doctors prescribe treatment for depression

Simple finger-prick blood test can help doctors prescribe treatment for depression

UCLA-led study to evaluate treatment strategies for older adults with depression

UCLA-led study to evaluate treatment strategies for older adults with depression

Study finds sex differences in smoking cessation with medications

Study finds sex differences in smoking cessation with medications

RedHill Biopharma and IntelGenx announce definitive agreement for commercialization of RIZAPORT™ for migraines with Grupo JUSTE in Spain and additional potential territories

RedHill Biopharma and IntelGenx announce definitive agreement for commercialization of RIZAPORT™ for migraines with Grupo JUSTE in Spain and additional potential territories

Bupropion, varenicline drugs do not increase risk of serious neuropsychiatric adverse events

Bupropion, varenicline drugs do not increase risk of serious neuropsychiatric adverse events

Antidepressant Wellbutrin linked to long-term modest weight loss

Antidepressant Wellbutrin linked to long-term modest weight loss

Orexigen Therapeutics, Valeant Pharmaceuticals sign distribution agreement for Mysimba

Orexigen Therapeutics, Valeant Pharmaceuticals sign distribution agreement for Mysimba

Review provides recommendations to improve cancer screening, treatment in people with mental illness

Review provides recommendations to improve cancer screening, treatment in people with mental illness

Smoking cessation medication 46% effective in women

Smoking cessation medication 46% effective in women

Studies suggests that insular cortex may hold key to treating addiction

Studies suggests that insular cortex may hold key to treating addiction

S1 Biopharma supports FDA's approval of flibanserin for women living with HSDD

S1 Biopharma supports FDA's approval of flibanserin for women living with HSDD

New prescription smoking-cessation drug not helping smokers quit

New prescription smoking-cessation drug not helping smokers quit

FDA accepts sNDA to review Brintellix clinical trial data for treatment of major depressive disorder

FDA accepts sNDA to review Brintellix clinical trial data for treatment of major depressive disorder

Orexigen Therapeutics provides update on business and financial results for Q1 2015

Orexigen Therapeutics provides update on business and financial results for Q1 2015

Eisai, Arena complete two Phase 1 registrational trials for once-daily formulation of lorcaserin

Eisai, Arena complete two Phase 1 registrational trials for once-daily formulation of lorcaserin

People who quit smoking have improved metabolic effects, new study finds

People who quit smoking have improved metabolic effects, new study finds

GeneSight test better predicts antidepressant outcomes for patients with depression

GeneSight test better predicts antidepressant outcomes for patients with depression

Extending use of bupropion before quitting reduces smoking behavior

Extending use of bupropion before quitting reduces smoking behavior